SPARC (osteonectin/BM-40)

International Journal of Biochemistry and Cell Biology

Volumn 31, Issue 12, 1999, Pages 1363-1366

  Motamed, Kouros ^a  

^a HOPE HEART INSTITUTE   (United States)

Author keywords

Angiogenesis; Cataracts; Extracellular matrix; Tumor growth

Indexed keywords

OSTEONECTIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CATARACT; EMBRYO DEVELOPMENT; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FAMILY; TISSUE REGENERATION;

ANIMALS; EMBRYONIC AND FETAL DEVELOPMENT; EXTRACELLULAR MATRIX; HUMANS; NEOPLASMS; OSTEONECTIN;

EID: 0032752257     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(99)00090-4     Document Type: Article

References (19)

1. Termine J.D., Kleinman H.K., Whitson S.W., Conn K.M., McGarvey M.L., Martin G.R. Osteonectin, a bone-specific protein linking mineral to collagen. Cell. 26:1981;99-105.
2. Sage E.H., Johnson C., Bornstein P. Characterization of a novel serum albumin-binding glycoprotein secreted by endothelial cells in culture. J. Biol. Chem. 259:1984;3993-4007.
3. Otsuka K., Yao K.L., Wasi S., Tung P.S., Aubin J.E., Sodek J., Termine J.D. Biosynthesis of osteonectin by fetal porcine calvarial cells in vitro. J. Biol. Chem. 259:1984;9805-9812.
4. Mason I.J., Taylor A., Williams J.G., Sage H., Hogan B.L. Evidence from molecular cloning that SPARC, a major product of mouse embryo parietal endoderm, is related to an endothelial "culture shock" glycoprotein. EMBO J. 5:1986;1465-1472.
5. Mann K., Deutzmann R., Paulsson M., Timpl R. Solubilization of protein BM-40 from a basement membrane tumor with chelating agents and evidence for its identity with osteonectin and SPARC. FEBS. 218:1987;167-172.
6. McVey J.H., Nomura S., Kelly P., Mason I.J., Hogan B.L. Characterization of the mouse SPARC/osteonectin gene: intron/exon organization and an unusual promoter region. J. Biol. Chem. 263:1988;11,111-11,116.
7. Maurer P., Hohenadl C., Hohenester E., Gohring W., Timpl R., Engel J. The C-terminal portion of BM-40 (SPARC/osteonectin) is an autonomously-folding and crystallisable domain that binds calcium and collagen IV. J. Molec. Biol. 253:1995;347-357.
8. Lane T.F., Sage E.H. The biology of SPARC, a protein that modulates cell-matrix interactions. FASEB J. 8:1994;163-173.
9. Iruela-Arispe M.L., Lane T.F., Redmond Reilly D., Bolender R., Kavanagh T.L., Sage E.H. Expression of SPARC during development of the chicken chorioallantoic membrane: Evidence for regulated proteolysis in vivo. Molec. Biol. Cell. 6:1995;327-343.
10. Sasaki T., Gohring W., Mann K., Maurer P., Hohenester E., Knauper V., Murphy G., Timpl R. Limited cleavage of extracellular matrix protein BM-40 by matrix metalloproteinases increases its affinity for collagens. J. Biol. Chem. 272:1997;9237-9243.
11. Shankavaram U.T., DeWitt D.L., Funk S.E., Sage E.H., Wahl L.M. Regulation of human monocyte matrix metalloproteinases by SPARC. J. Cell. Physiol. 173:1997;327-334.
12. Sage E.H. Pieces of eight:bioactive fragments of extracellular proteins as regulators of angiogenesis. Trends Cell. Biol. 7:1997;182-186.
13. Motamed K., Sage E.H. SPARC inhibits endothelial cell adhesion but not proliferation through a tyrosine phosphorylation-dependent pathway. J. Cell. Biochem. 70:1998;543-552.
14. Gilmour D.T., Lyon G.J., Carlton M.B., Sanes J.R., Cunningham J.M., Anderson J.R., Hogan B.L., Evans M.J., Colledge W.H. Mice deficient for the secreted glycoprotein SPARC/osteonectin/BM40 develop normally but show severe age-onset cataract formation and disruption of the lens. EMBO J. 17:1998;1860-1870.
15. Bassuk J.A., Birkebak T., Rothmier J.D., Clark J.M., Bradshaw A., Muchowski P.J., Howe C.C., Clark J.I., Sage E.H. Disruption of the Sparc locus in mice alters the differentiation of lenticular epithelial cells and leads to cataract formation. Exp. Eye Res. 6:1999;321-331.
16. Bradshaw A.D., Francki A., Motamed K., Howe C.C., Sage E.H. Primary mesenchymal cells isolated from SPARC-null mice exhibit altered morphology and rates of proliferation. Molec. Biol. Cell. 10:1999;1569-1579.
17. Porter P.L., Sage E.H., Lane T.F., Funk S.H., Gown A.M. Distribution of SPARC in normal and neoplastic tissues. J. Histochem. Cytochem. 43:1995;791-800.
18. Ledda F., Bravo A.I., Adris S., Bover L., Mordoh J., Podhajcer O.L. Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells. Nature Med. 3:1997;171-176.
19. 2+-binding module in BM-40. Nature Struct. Biol. 3:1996;67-73.